Dietary Iron Requirements
Dietary Iron Requirements in US Adults
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Stephen Hennigar, PhD
- Phone Number: 225-763-2612
- Email: stephen.hennigar@pbrc.edu
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Recruiting
- LSU Pennington Biomedical Research Center
-
Contact:
- Stephen Hennigar, PhD
- Phone Number: 225-763-2612
- Email: stephen.hennigar@pbrc.edu
-
-
New York
-
Ithaca, New York, United States, 14853
- Recruiting
- Cornell University
-
Contact:
- Kimberly O'Brien, PhD
- Phone Number: 607-255-3743
- Email: koo4@cornell.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Study Population
Description
Inclusion Criteria:
- Males and premenopausal females age 18-50 y
- Previously participated in an iron stable isotope study or willing to consume an oral stable iron isotope and undergo a one-year equilibration period
- Willing to refrain from iron-containing supplements for the duration of the study
- Willing to refrain from tobacco smoking for the duration of the study
- Have not donated blood 3 months prior to the start of the study and willing to refrain from donating blood for the duration of the study
- Willing to have blood stored for future use
- Able and willing to comply with study requirements and consent to participate
Exclusion Criteria:
- Females: pregnant or lactating or plans to become pregnant during the study period
- Inability to provide informed consent and engage in informed consent procedures
- Plans to relocate outside the study area
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: US males and premenopausal females
A representative sample of adult males and premenopausal females living in the US
|
Stable iron isotopes will be used to determine iron requirements.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Iron isotope composition in blood
Time Frame: 12 weeks
|
Tracer-to-tracee rate in venous blood samples collected at multiple time points
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2025-036-PBRC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.